Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13,227,514
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
247,864
-
Shares change
-
+65,313
-
Total reported value, excl. options
-
$285,030
-
Value change
-
+$101,430
-
Number of buys
-
6
-
Number of sells
-
8
-
Price
-
$1.17
Institutional Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q1 2025
As of 31 Mar 2025 Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 247,864 shares of stock of the company.
Largest 10 holders included AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, CONNING INC., VANGUARD GROUP INC, STATE STREET CORP, Federation des caisses Desjardins du Quebec, CITIGROUP INC, Tower Research Capital LLC (TRC), and OSAIC HOLDINGS, INC..
This table shows 18 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.